Regis Healthcare Limited (ASX:REG)
Australia · Delayed Price · Currency is AUD 8.05
+0.06 (0.75%)
Sep 12, 2025, 4:10 PM AEST
Regis Healthcare Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2016 - 2020 |
| 1,161 | 1,014 | 780.61 | 725.33 | 701.37 | Upgrade | |
Revenue Growth (YoY) | 14.52% | 29.90% | 7.62% | 3.42% | 3.47% | Upgrade |
Cost of Revenue | 961.52 | 838.8 | 647.27 | 609.61 | 574.43 | Upgrade |
Gross Profit | 199.77 | 175.25 | 133.34 | 115.72 | 126.93 | Upgrade |
Selling, General & Admin | 89.93 | 88.06 | 76.77 | 66.14 | 62.93 | Upgrade |
Operating Expenses | 139.74 | 216.14 | 203.24 | 169.25 | 106.82 | Upgrade |
Operating Income | 60.03 | -40.89 | -69.9 | -53.53 | 20.11 | Upgrade |
Interest Expense | -116.43 | -88.61 | -70.85 | -66.68 | -70.07 | Upgrade |
Interest & Investment Income | 118.48 | 85.5 | 63.58 | 62.45 | 64.4 | Upgrade |
Other Non Operating Income (Expenses) | -3.07 | -2.87 | -2.75 | -3.7 | -3.93 | Upgrade |
EBT Excluding Unusual Items | 59 | -46.86 | -79.92 | -61.46 | 10.52 | Upgrade |
Gain (Loss) on Sale of Assets | 3.43 | 5.06 | 11.65 | - | 2.82 | Upgrade |
Asset Writedown | 4.5 | - | 0.64 | 3.02 | 11.66 | Upgrade |
Other Unusual Items | 4.5 | 13.69 | 27.25 | 3.25 | 4.16 | Upgrade |
Pretax Income | 71.44 | -28.1 | -40.38 | -55.19 | 29.15 | Upgrade |
Income Tax Expense | 22.49 | -6.69 | -11.93 | -16.39 | 9.2 | Upgrade |
Net Income | 48.95 | -21.42 | -28.45 | -38.8 | 19.95 | Upgrade |
Net Income to Common | 48.95 | -21.42 | -28.45 | -38.8 | 19.95 | Upgrade |
Shares Outstanding (Basic) | 301 | 301 | 301 | 301 | 301 | Upgrade |
Shares Outstanding (Diluted) | 304 | 301 | 301 | 301 | 301 | Upgrade |
Shares Change (YoY) | 0.93% | 0.05% | 0.02% | -0.01% | 0.02% | Upgrade |
EPS (Basic) | 0.16 | -0.07 | -0.09 | -0.13 | 0.07 | Upgrade |
EPS (Diluted) | 0.16 | -0.07 | -0.09 | -0.13 | 0.07 | Upgrade |
Free Cash Flow | 219.64 | 186.57 | 53.73 | 67.6 | 87.75 | Upgrade |
Free Cash Flow Per Share | 0.72 | 0.62 | 0.18 | 0.23 | 0.29 | Upgrade |
Dividend Per Share | 0.162 | 0.129 | 0.095 | 0.058 | 0.066 | Upgrade |
Dividend Growth | 25.54% | 36.29% | 62.33% | -11.92% | 64.92% | Upgrade |
Gross Margin | 17.20% | 17.28% | 17.08% | 15.95% | 18.10% | Upgrade |
Operating Margin | 5.17% | -4.03% | -8.95% | -7.38% | 2.87% | Upgrade |
Profit Margin | 4.21% | -2.11% | -3.65% | -5.35% | 2.84% | Upgrade |
Free Cash Flow Margin | 18.91% | 18.40% | 6.88% | 9.32% | 12.51% | Upgrade |
EBITDA | 108.56 | 86.22 | 55.19 | 48.59 | 63.01 | Upgrade |
EBITDA Margin | 9.35% | 8.50% | 7.07% | 6.70% | 8.98% | Upgrade |
D&A For EBITDA | 48.53 | 127.11 | 125.09 | 102.12 | 42.9 | Upgrade |
EBIT | 60.03 | -40.89 | -69.9 | -53.53 | 20.11 | Upgrade |
EBIT Margin | 5.17% | -4.03% | -8.95% | -7.38% | 2.87% | Upgrade |
Effective Tax Rate | 31.48% | - | - | - | 31.56% | Upgrade |
Revenue as Reported | 1,292 | 1,118 | 897.61 | 796.95 | 784.4 | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.